Barriers and strategies to achieve a cure for HIV
- 1 June 2018
- journal article
- review article
- Published by Elsevier BV in The Lancet HIV
- Vol. 5 (6), e317-e328
- https://doi.org/10.1016/s2352-3018(18)30039-0
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Absence of Detectable HIV-1 Viremia after Treatment Cessation in an InfantNew England Journal of Medicine, 2013
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013
- Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1Proceedings of the National Academy of Sciences of the United States of America, 2013
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI StudyPLoS Pathogens, 2013
- Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1Molecular Therapy Nucleic Acids, 2013
- An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV TranscriptionCell Host & Microbe, 2012
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsNature Medicine, 2010
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell TransplantationNew England Journal of Medicine, 2009